Concepedia

Anastasia Ivanova

AI

Statistics

Publications

123

Citations

8.7K

H-Index

45

Active since

1998

Affiliations

University of North Carolina at Chapel Hill(Current)

UNC Lineberger Comprehensive Cancer Center

National Institute of Diabetes and Digestive and Kidney Diseases

Indiana University – Purdue University Indianapolis

National Institutes of Health

Anastasia Ivanova is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and biostatistics.

ORCID

Publications per year

1998–2024

123

Publications

123

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

Emma Rossi, Lynn D. Kowalski, Jennifer Scalici et al. · The Lancet Oncology · 2017 · 911 citations

, , +17

TBCRC 001: Randomized Phase II Study of Cetuximab in Combination With Carboplatin in Stage IV Triple-Negative Breast Cancer

Lisa A. Carey, Hope S. Rugo, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2012 · 493 citations · Full text

, , +17

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Carlos A. Ramos, Natalie S. Grover, Anne Beaven et al. · Journal of Clinical Oncology · 2020 · 380 citations · Full text

, , +17

A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients*

Shannon S. Carson, John P. Kress, Jo E. Rodgers et al. · Critical Care Medicine · 2006 · 334 citations

, , +17

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies

Robert Z. Orlowski, Peter M. Voorhees, Reynaldo Garcia et al. · Blood · 2004 · 319 citations

, , +17

1–5 of 123